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1. Introduction 
Free fatty acids (FFA) are bound by human serum 
albumin (HSA) as multiple complexes of FFA-HSA 
which are characterized by stepwise equilibrium 
constants [ 1 ] , leaving only minute amounts in the 
unbound form for uptake by tissues [2,3]. The 
bound FFA dissociates thus replenishing the supply 
of unbound FFA [3]. The distribution of FFA 
between the free form and fatty acid bound by HSA 
as multiple complexes of FFA-HSA can be computed 
[4] using stepwise equilibrium constants [5] and a 
computer program [6]. The purpose of the present 
report is to provide such values for six long fatty 
acids at different molar ratios of FFA/HSA. The 
implications of this theoretical analysis with respect 
to the delivery of FFA by HSA to tissues are also 
considered. 
2. Materials and methods 
The distribution of different FFA (12:0, 14:0, 
16:0,18:0,18:1 and 18:2) between the unbound 
form, the bound form and the amount bound as 
complexes with HSA was computed on an IBM 
370/l 68 computer [6] using stepwise equilibrium 
constants for the FFA [5]. The values used are in 
Bg.2. The protein concentration was 580 PM (4 g/dl), 
based upon a molecular weight of 69 000. 
3. Results and discussion 
3.1. Computed concentrations of unbound fatty acids 
and free protein 
As shown in fig.1, the computed level of unbound 
72 
FFA increased rapidly in a non-linear fashion, with 
quantitative differences due to the structures, as the 
concentration of FFA and the molar ratio of FFA to 
albumin increased. In all cases the unbound form 
amounted to only a small fraction of the total (less 
than 0.03%) which is in accord with experimental 
studies [2,3]. Figure 1 also shows the rapid decrease 
in free or uncomplexed protein as the concentration 
of FFA increased. 
3.2. Distribution of fatty acids among the complexes 
with HSA 
Graphic plots of the concentrations of the com- 
plexes as a function of the concentration of FFA and 
the molar ratios of FFA/HSA are presented in 
fig.2. At low molar ratios of FFA/HSA, the complex 
of one FFA per HSA would be the most abundant. 
However, as the total concentration of FFA increased 
there would be a progressive shift to complexes with 
greater numbers of FFA per HSA. Note the differences 
in the plots with differences in the structure of the 
fatty acid. 
3.3. A comparison of the contribution of the complexes 
in the delivery of different FFA to tissues 
Experimental studies of the delivery of FFA to 
tissues showed that about one-fourth of the circulating 
FFA was removed in transit through an organ such as 
the liver [7-91. In this study an analysis was made of 
the removal of one-fourth of the FFA at molar ratios 
of FFA/HSA of 0.5, 1.0,2.0, 3.0, and 4.0. For 
conciseness, table 1 only shows the contributions of 
the complexes when the molar ratio upon delivery 
to the tissue was 0.5 and 2.0 releasing 72.5 and 
290 pmol FFA, respectively. At a molar ratio of 
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0.5 (table 1 ,A), the complexes with one and two 
moles of FFA would contribute most of the FFA, 
while at a molar ratio of 2 (table 1 ,B) the higher 
complexes would provide greater portions of the FFA. 
At a molar ratio of 4, the complexes with 4 and 5 
moles of FFA would be the greatest contributors. The 
contributions of the complexes in the delivery of FFA 
are again influenced by the structure of the fatty acid. 
The amounts of FFA contributed were in great 
excess of the amounts which were unbound. This 
relationship can be expressed as the ratio of the amount 
of FFA contributed divided by the amount not bound, 
e.g., at a total FFA concentration of 1160 ,uM this 
ratio for each FFA were: 230 (12:0), 1277 (14:0), 
4677 (16:0), 9235 (18:0), 17 500 (18:l) and 2377 
(18: 2). This implies that the rate of dissociation of 
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Fig.1. Concentration of unbound FFA and free protein as a function of FFA/HSA molar ratio. The concentration of unbound 
fatty acid was computed using the association constants presented in fig.2 for a concentration of HSA of 580 PM. The curve for 
free protein is based upon calculations using the constants for palmitate; the others were similar but are not included for the 
sake of simplicity. 
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Table 1 
The amount of free fatty acid (~moIes/l) contributed by each complex as one-fourth of the FFA is removed at 
Fl:A/HSA molar ratios of 0.5 and 2 
- 
Complex Laurate Myristatc Palmitatc Stcaratc Oleatc Linoleatc 
(12:O) (14:O) (16:O) (18:O) (18: 1) (18:2) 
A. Molar ratio 0.5 
1 29.4 (4 1) 35.7 (49) 31.9 (44) 33.6 (46) 33.0 (46) 50.4 (70) 
2 34.4 (47) 31.4 (43) 32.7 (45) 33.4 (46) 33.0 (46) 19.9 (14) 
3 7.9 (11) 5.1 (7) 7.6 (10) 5.3 (7) 4.8 (7) 2.1 (3) 
4 0.7 (1) 0.2 (0) 0.4 (1) 0.2 (0) 0.4 (1) 0.1 (0) 
B. Molar ratio 2 
1 -55.0 (-19) -72.1 (-25) -65.5 ((23) -73.3 (-25) -66.3 (-23) -92.6 (-32) 
2 43.5 (15) 55.6 (19) 49.7 (17) 52.8 (22) 55.5 (19) 52.8 (18) 
3 160.2 (55) 193.8 (67) 214.6 (74) 213.0 (73) 157.0 (54) 183.6 (63) 
4 100.8 (35) 85.4 (29) 79.5 (27) 70.5 (24) 111.3 (38) 129.7 (45) 
5 36.2 (12) 23.1 (8) 10.8 (4) 14.4 (5) 30.7 (11) 15.6 (5) 
6 3.8 (1) 3.8 (1) 0.8 (0) 2.2 (1) 1.6 (1) 0.8 (0) 
7 0.2 (0) 
The values in the parentheses are the percent contribution of that site; the minus signs designate opposite changes 
resulting from redistribution. Changes less than 0.01 pmol/l are not included. The complex indicates the number of 
moles of II:A per mole of HSA. 
the FFA from the complexes with HSA could be a 
limiting factor in the clearance of FFA. If this is the 
case, the rate of blood flow through the organs would 
affect the clearance of the different FFA from the 
plasma. Such clearance would depend upon the 
relative contributions of the complexes with the high 
and intermediate number of molecules of FFA 
providing FFA to the cells at different rates. 
Since, according to the present analysis, the 
relative amounts of FFA removed from each com- 
plex changes as a function of both the molar ratio 
of FFA to HSA and the structure of the FFA, it 
seems possible that the removal of different FFA 
from the circulation is modulated by various factors: 
the molar ratio of FFA to albumin, the structure of 
the FFA, and the rate of blood flow through the 
organ.* Differences in these factors could account 
for some of the contradictory results noted in the 
experimental studies concerning the influence of the 
* The relative rates of uptake of different WA can be 
complicated in vivo because of the presence of variable 
amounts of other fatty acids competing for binding sites 
and other factors [4]. 
structure of the fatty acid on its relative rate of 
uptake [lo] . It is also conceivable from the present 
data that such variations could influence the results 
obtained using an individual radioactive fatty acid as 
a tracer to measure the rates of clearance of the 
exchangeable pool of FFA (11). A related observation 
[lo] is that under specific experimental conditions 
the uptake of FFA by the liver can be measured 
accurately with either palmitic or oleic acid as a tracer, 
although differences were observed in the fractional 
uptake of individual FFA. 
Acknowledgements 
This research was supported in part by a Grant 
HL 15698 from the USPHS. The expert technical 
assistance of Paul Nagy is gratefully appreciated. 
References 
111 
I21 
I31 
Spector, A. A. (1975) Lipid Res. 16, 165-179. 
Goodman, D. S. (1958) J. Clin. Invest. 37, 1729-1735. 
Spector, A. A., Steinberg, D. and Tanaka, A. (1965) 
J. Biol. Chem. 240, 1032-1041. 
75 
Volume 73, number 1 FEBS LETTERS January 1977 
141 Wosilait, W. D., Soler-Argilaga, C. and Nagy, P. (1976) 
Biochem. Biophys. Res. Commun. 71,419-426. 
[S] Ashbrook, J., Spector, A. A., Santos, E. C. and 
Fletcher, J. E. (1975) J. Biol. Chcm. 250, 2333-2338. 
[6J Wosilait, W. D. and Nagy, P. (1976) Comp. Prog. 
Biomed. 6, 232-248. 
[7] Basso, L. V. and Have], R. J. (I 970) J. Clin. Invest. 49, 
537-547. 
[ 81 Soler-Argilaga, C., Infantc, R., Polonovski, J. and 
Caroli, J. (1971) Biochim. Biophys. Acta 239, 154.-161. 
[9] Soler-Argilaga, C., Infante, R., Renaud, G. and 
Polonovski, J. (1974) Biochimie 56, 757-761. 
[IO] Soler-Argilaga, C., Infante, R. and Polonovski, .I. (1973) 
Biochim. Biophys. Acta 326, I67- 173. 
[ 111 Soler-Argilaga, C., Infante, R. and Polonovski, J. (1975) 
J. Lipid Res. 16, 116-122. 
76 
